ArticleOncotarget2017

The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis.

Bum Jun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.